| [1] |
ZHANG Tianyu, CHEN Fei, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia.
Significance of Elevated Levels of Leukocyte Immunoglobulin-like Receptor B1, CD36, and Lymphatic Enhancer Factor 1 in Patients with Myeloma
[J]. Chinese General Practice, 2026, 29(29): 4272-4280.
|
| [2] |
LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu.
Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia
[J]. Chinese General Practice, 2026, 29(29): 4248-4257.
|
| [3] |
GUO Junchi, ZHANG Mingyan, QIN Guangning, XU Qiang, LU Meijuan.
Preliminary Application of the Novel Biomarker TANS01 in Cardiovascular Risk Assessment among Individuals with Phlegm-dampness Constitution
[J]. Chinese General Practice, 2026, 29(27): 3924-3930.
|
| [4] |
WANG Wei, YU Fei, YAN Xiaohong.
Application and Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure with Different Etiologies: Evidence from Ischemic and Non-ischemic Heart Failure
[J]. Chinese General Practice, 2026, 29(27): 3976-3984.
|
| [5] |
YAN Yi, JIANG Yu, CHEN Bi, ZHANG Cantang, WANG Jing.
Study on the Predictive Value of a Multi-parameter Model Based on Lymphocyte Count for the Prognosis of Patients with Acute Exacerbation of Interstitial Lung Disease Complicated with Pulmonary Infection
[J]. Chinese General Practice, 2026, 29(26): 3760-3766.
|
| [6] |
ZHAO Yiru, HAO Xinyu, ZHAO Lei, ZHANG Caihui, WANG Zhaoxia, ZHANG Yueying.
Summary of the Best Evidence for the Management of Diuretic Resistance in Patients with Heart Failure
[J]. Chinese General Practice, 2026, 29(25): 3694-3703.
|
| [7] |
ZHAO Sinan, LIN Shan, KANG Xi, WANG Chunyan, WANG Shunxiang.
Impact of Immune Inhibitory Factors Programmed Cell Death Ligand 1 and T Cell Immunoglobulin Mucin-3 on the Prognosis of Hepatocellular Carcinoma Patients
[J]. Chinese General Practice, 2026, 29(24): 3461-3465.
|
| [8] |
LI Xueni, LIU Gejing, LIU Yongming.
Efficacy and Safety of Semaglutide in Patients with Heart Failure: a Meta-Analysis
[J]. Chinese General Practice, 2026, 29(24): 3509-3519.
|
| [9] |
WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin.
Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(22): 3154-3161.
|
| [10] |
HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian.
Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
[J]. Chinese General Practice, 2026, 29(21): 2950-2958.
|
| [11] |
LIU Yang, ZHOU Guoping, LI Xiaoshi, LI Ping, ZHANG Xin.
Impact of Acute Respiratory Distress Syndrome Etiology on the Prognostic Value of Driving Pressure: a Prospective Cohort Study
[J]. Chinese General Practice, 2026, 29(19): 2638-2647.
|
| [12] |
LUAN Xiaoqing, SUN Jingjing, LI Xiaoling, WANG Manxia.
Research Progress on Potential Biomarkers of Neuromyelitis Optica Spectrum Disorder
[J]. Chinese General Practice, 2026, 29(17): 2418-2424.
|
| [13] |
LI Shilong, WANG He, ZHOU Xiaoyu, FU Lei, ZHAO Zhuo, HUA Chengjun, SI Chunying.
Advances in the Study of Cardiac Macrophages in Heart Failure with Preserved Ejection Fraction
[J]. Chinese General Practice, 2026, 29(15): 2084-2091.
|
| [14] |
XIONG Siyu, LU Bing, JIANG Wenhong, YU Tingting.
Study on the Relationship between Fructose-1, 6-Bisphosphate Aldolase A Expression before and after Targeted Drug Resistance in Lung Adenocarcinoma and Patient Prognosis
[J]. Chinese General Practice, 2026, 29(14): 1883-1889.
|
| [15] |
SUN Xia, SHEN Wen, TANG Xiang, ZHONG Wei, WANG Kailin, DAI Zhiyin, ZHANG Chaopu, YUAN Wei, YUAN Guoyue.
Analysis of Clinical Characteristics in Dilated Cardiomyopathy Patients with Different Weight Statuses and the Influence of Weight Management on the Prognosis
[J]. Chinese General Practice, 2026, 29(11): 1448-1455.
|